NASDAQ:PTIX

Protagenic Therapeutics (PTIX) Stock Price, News & Analysis

$1.50
+0.01 (+0.67%)
(As of 05/17/2024 ET)
Today's Range
$1.32
$1.50
50-Day Range
$1.08
$1.82
52-Week Range
$0.68
$2.32
Volume
4,892 shs
Average Volume
7,762 shs
Market Capitalization
$6.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PTIX stock logo

About Protagenic Therapeutics Stock (NASDAQ:PTIX)

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

PTIX Stock Price History

PTIX Stock News Headlines

Protagenic Therapeutics Inc PTIX
PTIX Protagenic Therapeutics, Inc.
PTIX - Protagenic Therapeutics, Inc.
PTIX_old Historical Data
Protagenic Therapeutics, Inc. (PTIX)
See More Headlines
Receive PTIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/01/2024
Today
5/18/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTIX
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-5,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.48 per share

Miscellaneous

Free Float
2,794,000
Market Cap
$6.66 million
Optionable
Not Optionable
Beta
0.44
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Garo H. Armen Ph.D. (Age 71)
    Co-Founder & Executive Chairman of the Board
  • Dr. Alexander Kenneth Arrow C.F.A. (Age 53)
    M.D., CFO & Secretary
    Comp: $150k
  • Dr. Andrew Slee (Age 74)
    Chief Operating Officer
  • Dr. Robert Benjamin Stein M.D. (Age 73)
    Ph.D., Chief Medical Officer & Director

PTIX Stock Analysis - Frequently Asked Questions

How have PTIX shares performed in 2024?

Protagenic Therapeutics' stock was trading at $0.99 at the start of the year. Since then, PTIX shares have increased by 51.5% and is now trading at $1.5001.
View the best growth stocks for 2024 here
.

When is Protagenic Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our PTIX earnings forecast
.

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) released its earnings results on Monday, April, 1st. The company reported ($0.38) earnings per share (EPS) for the quarter.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PTIX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners